IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.3040
+0.0061 (2.03%)
At close: May 12, 2025, 4:00 PM
0.3099
+0.0059 (1.94%)
After-hours: May 12, 2025, 6:07 PM EDT
IGC Pharma Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for IGC Pharma stock have an average target of 3.88, with a low estimate of 3.50 and a high estimate of 4.25. The average target predicts an increase of 1,176.32% from the current stock price of 0.30.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 6, 2025.
Analyst Ratings
The average analyst rating for IGC Pharma stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Strong Buy Reiterates $3.5 | Strong Buy | Reiterates | $3.5 | +1,051.32% | Mar 6, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4 → $4.25 | Strong Buy | Maintains | $4 → $4.25 | +1,298.03% | Feb 24, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.75 → $4 | Strong Buy | Maintains | $3.75 → $4 | +1,215.79% | Dec 5, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.5 → $3.75 | Strong Buy | Maintains | $3.5 → $3.75 | +1,133.55% | Sep 3, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.25 → $3.5 | Strong Buy | Maintains | $3.25 → $3.5 | +1,051.32% | Jul 29, 2024 |
Financial Forecast
Revenue This Year
1.26M
from 1.35M
Decreased by -6.47%
Revenue Next Year
1.47M
from 1.26M
Increased by 16.45%
EPS This Year
-0.09
from -0.22
EPS Next Year
-0.09
from -0.09
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.3M | 1.6M | 1.6M |
| Avg | 1.3M | 1.5M | 1.5M |
| Low | 1.2M | 1.4M | 1.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.3% | 25.3% | 7.5% |
| Avg | -6.5% | 16.5% | 3.4% |
| Low | -9.6% | 9.1% | 0.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.07 | -0.07 | -0.09 |
| Avg | -0.09 | -0.09 | -0.09 |
| Low | -0.10 | -0.11 | -0.09 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.